Search for dissertations about: "Jan-Håkan Jansson"

Showing result 1 - 5 of 8 swedish dissertations containing the words Jan-Håkan Jansson.

  1. 1. Inflammation and lifestyle in cardiovascular medicine

    Author : Jonas Andersson; Kurt Boman; Jan-Håkan Jansson; Lars Johansson; Joep Perk; Umeå universitet; []
    Keywords : MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; C-reactive protein; cardiovascular disease; stroke; atrial fibrillation; lifestyle; interleukin-6; tumor necrosis factor-α; exercise; physical activity; obesity; the metabolic syndrome; fibrinolysis; Cardiology; Kardiologi; Cardiology; kardiologi;

    Abstract : Despite major advances in the treatment and prevention of atherosclerosis the last several decades, cardiovascular disease still accounts for the majority of deaths in Sweden. With the population getting older, more obese and with rising numbers of diabetics, the cardiovascular disease burden may increase further in the future. READ MORE

  2. 2. Fibrinolytic factors in relation to anthropometry and incident type 2 diabetes

    Author : Jenny Hernestål Boman; Lars Johansson; Jan-Håkan Jansson; Tomas Lindahl; Umeå universitet; []
    Keywords : MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICIN OCH HÄLSOVETENSKAP; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; MEDICAL AND HEALTH SCIENCES; folkhälsa; Public health; cardiovascular disease; hjärt- och kärlforskning;

    Abstract : Fibrinolytic imbalance is associated with cardiovascular disease and its risk factors. The longitudinal changes in the fibrinolytic factors tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1) and tPA/PAI-1 complex have been inadequately studied in the general population and in relation to incident type 2 diabetes mellitus (T2DM). READ MORE

  3. 3. Biomarkers and risk of intracerebral hemorrhage : population-based studies in northern Sweden

    Author : Kristina Johansson; Marcus Lind; Lars Johansson; Jan-Håkan Jansson; Arne Lindgren; Umeå universitet; []
    Keywords : MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Intracerebral hemorrhage; hemorrhagic stroke; factor XII; D-dimer; von Willebrand factor; ABO blood groups; phosphatidylethanol; alcohol; risk markers; biomarkers; Medicine; medicin;

    Abstract : BackgroundIntracerebral hemorrhage (ICH) is a disease associated with a high morbidity and mortality and treatment options for the condition are limited. Even though an ICH event usually comes as a surprise to the affected individual, pathogenetic processes often have occurred before the sudden ICH event and may have preceded disease onset by years. READ MORE

  4. 4. Epidemiology of venous thromboembolism with focus on risk markers

    Author : Magdalena Johansson; Lars Johansson; Marcus Lind; Jan-Håkan Jansson; Gerd Lärfars; Umeå universitet; []
    Keywords : MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Venous thromboembolism; venous thrombosis; deep vein thrombosis; pulmonary embolism; incidence; risk markers; diabetes; glucose; alcohol consumption; alcohol dependence; physical activity; medicin; Medicine;

    Abstract : Background: Venous thromboembolism (VTE) is a vascular disease with an incidence of approximately 140 cases per 100,000 person-years in adults. The incidence of VTE has increased over the last decades, and more than 20% of affected individuals die in the first year after diagnosis. READ MORE

  5. 5. Determinants of adverse events during oral anticoagulant treatment

    Author : Marcus Lind; Jan-Håkan Jansson; Lars Johansson; Kurt Boman; Sam Schulman; Umeå universitet; []
    Keywords : MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Oral anticoagulants; warfarin; mortality; bleeding; biomarkers; medicin; Medicine;

    Abstract : Treament with oral anticoagulation is highly effective in reducing the burden of thromboembolic complications in several clinical conditions. The number of patients receiving oral anticoagulation is growing steadily. InSwedenabout 1.5 percent of the population receives treatment. READ MORE